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Background: Metastatic cancers of the paratesticular tissue are very rare; however, the most frequent primary site
of spermatic cord metastasis is the gastrointestinal tract.
Case presentation: We recently observed two cases of late-onset metastatic adenocarcinoma of the spermatic
cord. Both patients complained of groin discomfort with a palpable mass in the scrotum and inguinal area. Radical
orchiectomy and adjuvant chemotherapy were performed in both patients. Although the prognosis of patients with
metastatic adenocarcinoma of the spermatic cord is typically poor, the prognosis of our patients was favorable after
follow-up for 14 to 18 months.
Conclusions: In patients with groin discomfort or swelling and a history of gastric cancer, metastatic
adenocarcinoma should be included in the differential diagnosis for early detection of tumors.
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Gastric cancer is the second most common cause of
cancer-related deaths worldwide. In Korea, gastric cancer
is the most common cancer, affecting over 25,000 individ-
uals annually [1]. Sites of recurrence of gastric cancer in-
clude the peritoneum, liver, bone marrow, lymph nodes,
and, very rarely, the paratesticular tissues including the
spermatic cord. The prognosis of a metastatic tumor of
the spermatic cord is unfavorable, as those tumors are
usually detected in the setting of disseminated diseases
[2]. Herein, we report two patients with gastric cancer re-
currence in the spermatic cord that occurred 6 to 7 years
after total and subtotal gastrectomy and adjuvant chemo-
therapy with favorable prognoses.
Case presentation
Case 1
A 49-year-old man was referred to the Outpatient
Department at Soonchunhyang University Cheonan Hos-
pital (Cheonan, Korea) with a palpable mass in his right
scrotum and discomfort in the spermatic cord persisting* Correspondence: urokds@schmc.ac.kr
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unless otherwise stated.for 2 months. The mass was characterized with an insidi-
ous onset; it gradually increased in size. Seven years previ-
ously, the patient had undergone subtotal gastrectomy
with gastrojejunostomy, segmental resection of the trans-
verse colon, and end-to-end anastomosis for advanced
gastric cancer. Histologic examination of the specimen re-
vealed mucinous adenocarcinoma with signet ring cell
carcinoma (T3N2M0, stage IV). The patient had received
adjuvant chemotherapy with six cycles of 5-fluorouracil
and cisplatin. The patient had been followed-up for 7 years
on an outpatient basis, and he had not shown any sign of
recurrence.
On physical examination, a 3- × 2-cm mass was pal-
pated above the right testis. The mass was hard, nodular,
and non-tender. Scrotal ultrasonography revealed a 3- ×
2-cm-sized heterogeneous mass with irregular contours
in the right epididymal head, and it extended into the
spermatic cord (Figure 1a).
The patient underwent transinguinal exploration. Fro-
zen biopsy revealed a mucinous carcinoma of the epi-
didymis. The specimen was removed via radical inguinal
orchiectomy. Grossly, the specimen was an ill-defined
grayish-white solid mass (4.0 × 1.5 × 1.5 cm) in the epi-
didymis and spermatic cord (Figure 2a). Histopathological
examination revealed adenocarcinoma with signet ring
cells in the epididymis, spermatic cord, and soft tissue. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Ultrasonography, CT, and MRI. (a) Case 1: scrotal ultrasonography revealed an ill-defined heterogeneous mass (white arrow)
in the spermatic cord and epididymis. (b) Case 2: inguinal ultrasonography revealed an ill-defined heterogeneous mass (white arrow) of the
spermatic cord in the inguinal area, and (c,d) CT and MRI revealed an ill-defined enhancing mass (white arrows), longitudinally along the inguinal
tract. CT, computed tomography; MRI, magnetic resonance imaging.
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were focally positive for cytokeratin 7/20 and negative for
prostate specific antigen (PSA), consistent with previous
findings of gastric cancer.
We performed systemic reevaluation including gastro-
duodenoscopy, total colonoscopy, abdominal computed
tomography (CT), and total-body positron emission tom-
ography (PET), none of which could confirm another pri-
mary tumor. The levels of tumor markers such as PSA,
carcinoembryonic antigen (CEA), beta-human chorionic
gonadotrophin (β-HCG), alpha-fetoprotein (AFP), carbo-
hydrate antigen 19–9 (CA19-9), and cancer antigen 125
(CA125) were normal. The patient received eight courses
of adjuvant chemotherapy with the FOLFOX regimen
(folinic acid, fluorouracil, oxaliplatin). He has been doing
well with no evidence of recurrence after radical orchiec-
tomy at 26 months of follow-up.
Case 2
A 60-year-old man presented to the Urology Department
at Soonchunhyang University Seoul Hospital with left
inguinal pain for 1 month. The patient had a history
of T3M3M0 gastric adenocarcinoma and moderatedifferentiation 6 years previously. He had been treated
with total gastrectomy followed by three cycles of capecit-
abine and cisplatin chemotherapy. After chemotherapy,
the patient had no evidence of recurrence of cancer at the
6-year follow-up. Results of laboratory tests including the
levels of the tumor markers, including PSA, CEA,
CA19-9, β-HCG, AFP, and CA125, were within the nor-
mal range. Physical examination revealed moderate right
scrotal tenderness and inguinal tenderness. Chest radiog-
raphy did not reveal anything abnormal; the results of
hematological and biochemical tests were within normal
limits. Ultrasonography, pelvic CT, and magnetic reson-
ance imaging (MRI) revealed a soft tissue mass with ir-
regular margins in the spermatic cord (Figure 1b,c,d). The
patient underwent radical orchiectomy via an inguinal ap-
proach. Gross findings revealed an ill-defined grayish-
white solid mass (2.0 × 3.5 × 1.5 cm) in the spermatic cord
(Figure 2b). Pathological analysis revealed mucinous
adenocarcinoma with moderate differentiation (Figure 3b).
All resection margins were free of carcinoma. Immunohis-
tochemical staining for D2-40 did not reveal any lymph-
atic invasion. After the patient recovered from radical
orchiectomy, colonoscopic biopsy was performed for
Figure 2 Gross examination. Gross examination showed an ill-defined grayish-white solid mass (white arrows) in the epididymis and spermatic
cord. (a) Case 1. (b) Case 2.
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with moderate differentiation. Ten cycles of adjuvant radi-
ation therapy were administered. At the 20-month follow-
up, the patient was stable and demonstrated no recur-
rence of cancer.
Discussion
Metastatic tumors of the spermatic cord are rare [3].
The most common primary site of spermatic cord metas-
tasis is the gastrointestinal tract, followed by the pancreas,Figure 3 Histological analysis. Histological analysis revealed an adeno
(b) Case 2: stomach (H & E staining, 400×). Immunohistochemical staining
(d) Case 2: stomach (400×). H & E, hematoxylin and eosin.prostate, and kidneys [4]. The mechanisms involved in
metastasis to the spermatic cord and epididymis from pri-
mary malignant neoplasms are unclear. However, several
routes have been proposed [3]. The main routes are the
hematogenous or lymphatic routes, but other routes in-
cluding retrograde extension through the vessel, either
along its lumen or by direct extension via the wall of the
vessel, and transperitoneal seeding through the patent tu-
nica vaginalis have been proposed [3,4]. In the cases we
have discussed here, the possibility of hematogenous orcarcinoma with signet ring cells. (a) Case 1: epididymal tubules.
revealed a cytokeratin 7-positive mass. (c) Case 1: epididymal tubules.
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hydrocele was noted, which indicates that lymphatic drain-
age could be impaired, leading to congestion.
Moon et al. [5] have recently suggested that tumor
factors, including the stage, were clinical prognostic in-
dicators within 5 years post-gastrectomy, but there were
no such indicators after 5 years.
In patients with advanced gastric carcinoma undergoing
radical gastrectomy and adjuvant chemotherapy, approxi-
mately half the patients survive for > 5 years [5]. After gas-
trectomy, 8.8% of patients relapse with the predominant
pattern of distant metastasis (34.6%) during the 5 to 10 years
after surgery. However, recurrences many years after treat-
ment may be related to the activation of long-lasting tumor
dormancy, particularly in distant organs [5].
The prognosis of a metastatic tumor of the epididymis
and spermatic cord is typically unfavorable [2], as meta-
static tumors to the paratesticular tissues are usually de-
tected in the setting of disseminated diseases. However,
previous reports of metastatic tumors of the epididymis
and spermatic cord from gastric cancer were published
in 1980 to 1990. During the last two decades, chemo-
therapy including adjuvant chemotherapy has evolved
significantly in both its efficacy and toxicity. The main
reasons that our patients had favorable outcomes were
owing to the relatively early detection because of the de-
velopment of radiologic imaging, and also owing to the
effect of adjuvant chemotherapy. Earlier reports might not
have considered the positive effect of adjuvant chemother-
apy. Considering these diseases in the differential diagno-
sis of a groin mass when a history of gastrointestinal tract
cancer is present can be critical for a more precise diagno-
sis and more targeted treatment.
Conclusion
Metastatic lesions of the spermatic cord should be in-
cluded in the differential diagnosis of a scrotal or in-
guinal mass with discomfort, especially in patients with
a history of gastrointestinal cancer, to promptly achieve
a targeted treatment.
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